Relmada Therapeutics
RLMD
RLMD
83 hedge funds and large institutions have $56.7M invested in Relmada Therapeutics in 2023 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 27 increasing their positions, 19 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
4.23% less ownership
Funds ownership: 49.78% → 45.55% (-4.2%)
79% less call options, than puts
Call options by funds: $296K | Put options by funds: $1.41M
Holders
83
Holding in Top 10
–
Calls
$296K
Puts
$1.41M
Top Buyers
| 1 | +$3.51M | |
| 2 | +$1.03M | |
| 3 | +$910K | |
| 4 |
Two Sigma Advisers
New York
|
+$679K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$636K |
Top Sellers
| 1 | -$6.4M | |
| 2 | -$3.28M | |
| 3 | -$478K | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$328K |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
-$274K |